CONMED Net Profit Margin 2010-2024 | CNMD
CONMED net profit margin from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
| CONMED Net Profit Margin Historical Data |
| Date |
TTM Revenue |
TTM Net Income |
Net Margin |
| 2024-09-30 |
$1.29B |
$0.13B |
10.25% |
| 2024-06-30 |
$1.28B |
$0.10B |
7.76% |
| 2024-03-31 |
$1.26B |
$0.08B |
6.58% |
| 2023-12-31 |
$1.25B |
$0.07B |
5.22% |
| 2023-09-30 |
$1.17B |
$0.06B |
5.05% |
| 2023-06-30 |
$1.14B |
$0.09B |
7.81% |
| 2023-03-31 |
$1.10B |
$-0.09B |
-8.47% |
| 2022-12-31 |
$1.05B |
$-0.08B |
-7.66% |
| 2022-09-30 |
$1.07B |
$-0.08B |
-7.77% |
| 2022-06-30 |
$1.04B |
$-0.11B |
-10.94% |
| 2022-03-31 |
$1.02B |
$0.07B |
6.57% |
| 2021-12-31 |
$1.01B |
$0.06B |
6.13% |
| 2021-09-30 |
$0.99B |
$0.06B |
6.26% |
| 2021-06-30 |
$0.98B |
$0.05B |
5.52% |
| 2021-03-31 |
$0.88B |
$0.01B |
1.59% |
| 2020-12-31 |
$0.86B |
$0.01B |
1.16% |
| 2020-09-30 |
$0.88B |
$0.00B |
0.11% |
| 2020-06-30 |
$0.87B |
$0.00B |
0.11% |
| 2020-03-31 |
$0.95B |
$0.03B |
3.58% |
| 2019-12-31 |
$0.96B |
$0.03B |
3.04% |
| 2019-09-30 |
$0.93B |
$0.03B |
3.22% |
| 2019-06-30 |
$0.90B |
$0.03B |
3.22% |
| 2019-03-31 |
$0.88B |
$0.03B |
3.66% |
| 2018-12-31 |
$0.86B |
$0.04B |
4.89% |
| 2018-09-30 |
$0.84B |
$0.07B |
8.69% |
| 2018-06-30 |
$0.83B |
$0.07B |
8.94% |
| 2018-03-31 |
$0.81B |
$0.07B |
8.74% |
| 2017-12-31 |
$0.80B |
$0.06B |
6.90% |
| 2017-09-30 |
$0.78B |
$0.02B |
1.93% |
| 2017-06-30 |
$0.77B |
$0.02B |
1.94% |
| 2017-03-31 |
$0.77B |
$0.01B |
1.56% |
| 2016-12-31 |
$0.76B |
$0.02B |
1.97% |
| 2016-09-30 |
$0.75B |
$0.02B |
2.13% |
| 2016-06-30 |
$0.73B |
$0.02B |
2.45% |
| 2016-03-31 |
$0.72B |
$0.02B |
3.05% |
| 2015-12-31 |
$0.72B |
$0.03B |
4.17% |
| 2015-09-30 |
$0.72B |
$0.03B |
4.56% |
| 2015-06-30 |
$0.73B |
$0.03B |
3.57% |
| 2015-03-31 |
$0.74B |
$0.03B |
3.94% |
| 2014-12-31 |
$0.74B |
$0.03B |
4.32% |
| 2014-09-30 |
$0.75B |
$0.03B |
4.14% |
| 2014-06-30 |
$0.75B |
$0.04B |
4.65% |
| 2014-03-31 |
$0.76B |
$0.04B |
4.62% |
| 2013-12-31 |
$0.76B |
$0.04B |
4.72% |
| 2013-09-30 |
$0.76B |
$0.04B |
4.87% |
| 2013-06-30 |
$0.76B |
$0.04B |
5.24% |
| 2013-03-31 |
$0.76B |
$0.04B |
5.26% |
| 2012-12-31 |
$0.77B |
$0.04B |
5.22% |
| 2012-09-30 |
$0.75B |
$0.00B |
0.53% |
| 2012-06-30 |
$0.74B |
$0.00B |
0.40% |
| 2012-03-31 |
$0.74B |
$0.00B |
0.27% |
| 2011-12-31 |
$0.73B |
$0.00B |
0.14% |
| 2011-09-30 |
$0.72B |
$0.03B |
4.56% |
| 2011-06-30 |
$0.72B |
$0.03B |
4.71% |
| 2011-03-31 |
$0.72B |
$0.03B |
4.44% |
| 2010-12-31 |
$0.71B |
$0.03B |
4.21% |
| 2010-09-30 |
$0.72B |
$0.03B |
3.89% |
| 2010-06-30 |
$0.72B |
$0.02B |
2.77% |
| 2010-03-31 |
$0.71B |
$0.01B |
1.98% |
| 2009-12-31 |
$0.70B |
$0.01B |
1.58% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$2.162B |
$1.245B |
|
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
|
